BioCircuit Technologies Announces FDA 510(k) Clearance of Nerve Tape® Device
21 juil. 2022 11h47 HE
|
BioCircuit Technologies
Atlanta, GA, July 21, 2022 (GLOBE NEWSWIRE) -- BioCircuit Technologies®, a National Institutes of Health (NIH)-funded medical device company focused on tissue repair and neuromodulation, announced...